Insulin Degludec/Liraglutide Appears to Outperform Glargine in Type 2 Diabetes (FREE)
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
In adults with uncontrolled type 2 diabetes, insulin degludec/liraglutide is noninferior to insulin glargine and may in fact be superior, … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 2, 2016 Category: Primary Care Source Type: news
Degludec-Liraglutide Combo Superior to Standard of Care (CME/CE)
(MedPage Today) -- IDegLira passes phase III trial (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - March 1, 2016 Category: Pediatrics Source Type: news
Degludec/liraglutide noninferior to uptitrated glargine
For adults whose type 2 diabetes is not controlled by glargine plus metformin, switching from glargine to combination degludec/liraglutide lowered hemoglobin A1c levels to a noninferior... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 1, 2016 Category: Endocrinology Source Type: news
Liraglutide may have diminishing effect with long-term use
A study published in Cell Metabolism by researchers in Miami found that long term daily doses of liraglutide in mice gradually weakened cells' ability to produce insulin in response to glucose.
Medical Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 12, 2016 Category: Endocrinology Source Type: news
Medical News Today: Type 2 diabetes: long-term liraglutide use may raise blood sugar levels
While liraglutide is prescribed for some type 2 diabetes patients to lower blood sugar levels, a new study suggests using the drug long term may have the opposite effect. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 12, 2016 Category: Consumer Health News Tags: Diabetes Source Type: news
Type 2 diabetes drug can exhaust insulin-producing cells
Long-term use of liraglutide, a substance that helps to lower blood sugar levels in patients with type 2 diabetes, can have a deteriorating effect on insulin-producing beta cells, leading to an increase in blood sugar levels, an international team of researchers warns. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 11, 2016 Category: Science Source Type: news
Type 2 diabetes drug can exhaust insulin-producing cells
Long-term use of liraglutide, a substance that helps to lower blood sugar levels in patients with type 2 diabetes, can have a deteriorating effect on insulin-producing beta cells, leading to an increase in blood sugar levels. This according to a study on mice implanted with human insulin-producing cells conducted by a team of scientists from Karolinska Institutet, Sweden, and the University of Miami, USA. (Source: World Pharma News)
Source: World Pharma News - February 11, 2016 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
LIRA-RENAL: Liraglutide Safe in Diabetes With Renal FailureLIRA-RENAL: Liraglutide Safe in Diabetes With Renal Failure
Data from the LIRA-RENAL study detailing use of liraglutide in patients with type 2 diabetes and moderate kidney disease have been published. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 24, 2015 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Early weight loss with liraglutide predicts long-term success
Adults who achieve at least 5% weight loss after 16 weeks of liraglutide therapy are more likely to achieve greater than 10% weight loss at 1 year than those with less early weight reduction, according to study findings presented at the Diabetes World Congress 2015.
Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 14, 2015 Category: Endocrinology Source Type: news
No Effect on HbA1c for Liraglutide + Insulin in Type 1 Diabetes No Effect on HbA1c for Liraglutide + Insulin in Type 1 Diabetes
A Danish study showed no effect on HbA1c for liraglutide added to insulin in overweight adults with type 1 diabetes; therefore, its use can't currently be recommended, says lead author. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 10, 2015 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Diabetes drug could be used to combat fatty liver disease, research shows
Findings from a new study present the possibility of new therapies for patients with non-alcoholic fatty liver disease, for which there is no current licensed treatment. The trial was the first of its type to look into the action of liraglutide in the treatment of non-alcoholic steatohepatitis. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 20, 2015 Category: Science Source Type: news
Liraglutide No Match for Heart Failure in Early Round of FIGHTLiraglutide No Match for Heart Failure in Early Round of FIGHT
In the FIGHT trial of patients with advanced HF, the GLP-1 agonist liraglutide did not improve survival or rates of rehospitalization at 6 months. Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2015 Category: Consumer Health News Tags: Cardiology News Source Type: news
Novo Nordisk diabetes drug fails to help heart failure: study
ORLANDO (Reuters) - The Novo Nordisk diabetes drug Victoza failed to improve clinical stability or delay death in patients suffering from advanced heart failure, researchers reported at a medical meeting on Sunday. (Source: Reuters: Health)
Source: Reuters: Health - November 8, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
Liraglutide Effective After 3 Years for Prediabetes
(MedPage Today) -- Patients kept weight off with diet and exercise (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 6, 2015 Category: Cardiology Source Type: news
Liraglutide Plus Insulin Tied to Better Glycemic Control in Later Stages of Type 2 Diabetes (FREE)
By Kelly Young
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
The addition of liraglutide to insulin injections in patients with long-standing type 2 diabetes is associated with … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 30, 2015 Category: Primary Care Source Type: news
